KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Accounts Payables (2016 - 2025)

Historic Accounts Payables for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $11.6 million.

  • CareDx's Accounts Payables rose 8587.91% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 8587.91%. This contributed to the annual value of $7.7 million for FY2024, which is 4028.9% down from last year.
  • According to the latest figures from Q3 2025, CareDx's Accounts Payables is $11.6 million, which was up 8587.91% from $9.9 million recorded in Q2 2025.
  • Over the past 5 years, CareDx's Accounts Payables peaked at $16.9 million during Q2 2022, and registered a low of $5.9 million during Q2 2024.
  • Its 5-year average for Accounts Payables is $10.8 million, with a median of $10.6 million in 2022.
  • Its Accounts Payables has fluctuated over the past 5 years, first plummeted by 4151.08% in 2023, then surged by 8587.91% in 2025.
  • Quarter analysis of 5 years shows CareDx's Accounts Payables stood at $13.3 million in 2021, then dropped by 25.46% to $9.9 million in 2022, then rose by 29.47% to $12.9 million in 2023, then tumbled by 40.29% to $7.7 million in 2024, then soared by 50.88% to $11.6 million in 2025.
  • Its Accounts Payables stands at $11.6 million for Q3 2025, versus $9.9 million for Q2 2025 and $8.1 million for Q1 2025.